Total Payments
$9,138
2024 Payments
$971.25
Companies
63
Transactions
620
Medicare Patients
1,144
Medicare Billing
$93,679
Payment Breakdown by Category
Food & Beverage$9,138 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,138 | 620 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,085 | 78 | $0 (2024) |
| Novo Nordisk Inc | $894.73 | 76 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $875.52 | 34 | $0 (2024) |
| Lilly USA, LLC | $721.35 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $673.69 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $626.60 | 59 | $0 (2023) |
| Amarin Pharma Inc. | $411.99 | 33 | $0 (2021) |
| Astellas Pharma US Inc | $395.50 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $390.91 | 31 | $0 (2022) |
| GlaxoSmithKline, LLC. | $336.94 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $971.25 | 47 | ABBVIE INC. ($144.53) |
| 2023 | $1,465 | 92 | ABBVIE INC. ($244.56) |
| 2022 | $1,441 | 96 | ABBVIE INC. ($215.47) |
| 2021 | $1,360 | 97 | AbbVie Inc. ($289.63) |
| 2020 | $1,161 | 78 | Amarin Pharma Inc. ($237.93) |
| 2019 | $1,204 | 95 | Merck Sharp & Dohme Corporation ($189.30) |
| 2018 | $1,220 | 94 | SANOFI-AVENTIS U.S. LLC ($163.55) |
| 2017 | $316.48 | 21 | Novo Nordisk Inc ($67.84) |
All Payment Transactions
620 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: VACCINES | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Biological | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: VACCINES | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Biological | ||||||
| 08/16/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Durable Pump | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), SYNJARDY, JARDIANCE | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Diabetes Care | ||||||
| 06/04/2024 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: Devices | ||||||
| 05/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Biological | ||||||
| 05/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Bone Health | ||||||
| 05/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: DIABETES | ||||||
| 05/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 310 | 394 | $62,385 | $31,123 |
| 2022 | 5 | 254 | 309 | $48,675 | $22,873 |
| 2021 | 7 | 290 | 339 | $41,630 | $21,955 |
| 2020 | 9 | 290 | 326 | $33,245 | $17,727 |
Total Patients
1,144
Total Services
1,368
Medicare Billing
$93,679
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 168 | $29,400 | $12,729 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $15,180 | $8,334 | 54.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 46 | 46 | $4,600 | $3,411 | 74.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 40 | $5,800 | $2,211 | 38.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $2,640 | $1,731 | 65.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $2,925 | $1,358 | 46.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 46 | 46 | $1,840 | $1,349 | 73.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 117 | $20,475 | $8,700 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $14,740 | $8,259 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 64 | $9,280 | $3,111 | 33.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 29 | 29 | $2,900 | $1,967 | 67.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 32 | 32 | $1,280 | $836.37 | 65.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 62 | 62 | $13,640 | $7,917 | 58.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 90 | $15,750 | $7,026 | 44.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 74 | $9,250 | $4,526 | 48.9% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 17 | 17 | $1,160 | $1,043 | 89.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 66 | 66 | $990.00 | $975.00 | 98.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $540.00 | $274.55 | 50.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 12 | 12 | $300.00 | $193.96 | 64.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 58 | 58 | $12,770 | $6,614 | 51.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 59 | $8,840 | $4,236 | 47.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 65 | $6,500 | $2,714 | 41.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 13 | 13 | $1,350 | $1,334 | 98.8% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 20 | 20 | $1,270 | $1,198 | 94.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 57 | 57 | $855.00 | $867.39 | 101.4% |
About Dr. Allen Freestone, MD
Dr. Allen Freestone, MD is a Family Medicine healthcare provider based in Bountiful, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801850755.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allen Freestone, MD has received a total of $9,138 in payments from pharmaceutical and medical device companies, with $971.25 received in 2024. These payments were reported across 620 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($9,138).
As a Medicare-enrolled provider, Freestone has provided services to 1,144 Medicare beneficiaries, totaling 1,368 services with total Medicare billing of $93,679. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bountiful, UT
- Active Since 04/15/2006
- Last Updated 10/16/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801850755
Products in Payments
- VRAYLAR (Drug) $619.97
- TRADJENTA (Drug) $500.47
- Vascepa (Drug) $411.99
- JANUVIA (Drug) $372.78
- FARXIGA (Drug) $331.69
- BREZTRI (Drug) $325.86
- Ozempic (Drug) $295.07
- MYRBETRIQ (Drug) $266.88
- TRULICITY (Drug) $247.19
- NURTEC ODT (Drug) $206.78
- JARDIANCE (Drug) $201.53
- TOUJEO (Drug) $185.30
- Rybelsus (Drug) $175.03
- TRELEGY ELLIPTA (Drug) $171.65
- QULIPTA (Drug) $158.09
- UBRELVY (Drug) $141.65
- SHINGRIX (Biological) $137.13
- Kerendia (Drug) $134.83
- EMGALITY (Drug) $132.53
- Veozah (Drug) $128.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bountiful
Scott Erickson
Family Medicine — Payments: $135,999
Family Medicine $135,999
David Cope, Md, MD
Family Medicine — Payments: $6,614
Family Medicine $6,614
William Draper, Do, DO
Family Medicine — Payments: $5,187
Family Medicine $5,187
Dr. Antonina Callahan, Md, MD
Family Medicine — Payments: $4,441
Family Medicine $4,441
Dr. Brian Rodgers, D. O, D. O
Family Medicine — Payments: $4,368
Family Medicine $4,368
Allison Hanna, D.o, D.O
Family Medicine — Payments: $2,662
Family Medicine $2,662